Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

Championing domestic financing to promote a vibrant vaccine research and development enterprise in Africa

February 7, 2024

Advocating for financing for vaccine and health research, development, and innovation for Africa by Africa.

Read more

Features

Penta – Child Health Research announces new partnership with IAVI and Achilles Vaccines

February 1, 2024

Partnership will advance monoclonal antibody development.

Read more

Features

IAVI recommends new business models for increasing access to monoclonal antibodies

January 4, 2024

New approaches could help advance access to a promising medical innovation, consortium finds.

Read more

Features

Development of the candidate tuberculosis vaccine H56:IC31 ended based on early data from the Prevention of Recurrence TB Consortium

December 19, 2023

Vaccine well tolerated and demonstrated immunogenicity but did not provide protection against TB recurrence; participants being informed; further analysis continues.

Read more

Features

Meet The Scientist podcast: An interview with Joyeeta Mukherjee, Ph.D., associate director at IAVI, on the intersection of community and science

December 6, 2023

In this episode of Meet the Scientist, IAVI's podcast series, we explore the pivotal significance of community engagement in global collaborative research.

Read more

Features

IAVI statement on PrEPVacc trial

December 6, 2023

Trial will stop vaccinations due to lack of efficacy.

Read more

Features

The moment is now: navigating the path to TB vaccine success at the Union Conference and beyond

December 6, 2023

This year’s Union Conference set the scene for what could be the biggest year to date for tuberculosis (TB) vaccines.

Read more

Features

This World AIDS Day, celebrating community leadership

December 1, 2023

“Science, when it is inclusive, becomes a powerful tool for change,” says IAVI’s Monica Kuteesa.

Read more